Kowalski will be coordinating all programming for the conference and will lead the committees making important decisions regarding the event.
Cannabis Science Conference (CSC), the premier cannabis science conference focusing on analytical science, medical cannabis, cultivation, and compliance, has named Julie Kowalski, a distinguished figure in the cannabis science industry, Director of Technical Programming for CSC Spring 2024. The conference is scheduled for May 7–9, 2024, in Kansas City, Missouri, at the Kansas City Marriott Downtown.
Kowalski began working on gas chromatographs at age 20, adding liquid chromatography to her skills soon after. Since then, she has been a constant presence in the lab, pioneering cannabis analysis. A trailblazer in the field, Kowalski applied her expertise in chemical contaminants to cannabis testing in the early days of recreational cannabis legalization in the United States. Recently, she launched a consulting business, JA Kowalski Science Support, LLC, where she provides her expertise on cannabis testing.
As the director, Kowalski will be tasked with coordinating all programming for the conference and leading the committees through decision-making, such as selecting expert speakers, curating content and building the conference schedule.
“This role brings together my love of science, collaboration and cannabis,” said Kowalski. “Our team is working to create a productive space for cannabis science stakeholders to learn from each other, build valuable relationships, join forces, and empathize. At this juncture, the industry is at an inflection point and needs a strong scientific community to raise the bar. We are focused on building consensus technical programming via our wonderful track chairs and organizing committee members and welcome all input.”
Attendees will experience a lineup of interactive workshops, hands-on demonstrations, and expert-led sessions. They will have the chance to engage with industry experts, thought leaders, and fellow attendees in an intimate and collaborative setting. This environment will equip them with the latest insights and trends in the cannabis field.
Join Cannabis Science Conference Spring for world-class education, networking opportunities and the chance to connect with thought leaders, leading scientists, pioneers in cutting-edge medical applications and industry suppliers.
For event details and registration, please visit the event page.
Ep 24, Part II: Data Transparency in Cannabis Testing with Yasha Khan
December 12th 2024Evan Friedmann and Yasha Kahn, co-founder of MCR Labs, discuss the discrepancies between current regulations and data on mycotoxins and pesticides in cannabis products. They highlight the need for updated regulations based on new data, emphasizing the importance of accurate testing and labeling. They also discuss the issue of result manipulation, particularly in THC content, and the need for public health officials to address this. Yasha suggests making testing data public to enhance oversight and suggests a national entity to manage this data for better consistency and public safety.
Ep 24, Part I: Data Transparency in Cannabis Testing with Yasha Khan
November 21st 2024Evan Friedmann interviews Yasha Khan, co-founder of MCR Labs, about his journey into the cannabis industry and his efforts to promote transparency and integrity in laboratory practices. Yasha discusses the origins of MCR Labs, which began in Massachusetts to meet the needs of the soon-to-be legal medical cannabis market. He explains the challenges faced, including result manipulation by labs and the impact on public health. Yasha's Freedom of Information Act (FOIA) project aimed to gather testing data from 37 states, revealed significant discrepancies in potency and mold results. Despite some states' reluctance to share data, Yasha has made much of this data public, leading to collaborative research and publications on various aspects of cannabis testing.